Vol 1 (April 2020): Translational Breast Cancer Research

Meet the Professor 
Dr. Zefei Jiang: our journey beyond the stars and seas
Jessica Liao
Translational Breast Cancer Research  
2020;
1:
9  
Case Report 
Pyrotinib for metastatic breast cancer after multi-anti-HER2 targeted therapy: a case report
Feng Li, Li Bian, Zerui Qu, Jianbin Li, Fengrui Xu, Zefei Jiang
Translational Breast Cancer Research  
2020;
1:
8  
Case Report 
Optimized first-line therapy for stage IV breast cancer brings long-term disease-free survival: a case report and biological analysis
Li Bian, Fengrui Xu, Tao Wang, Huiqiang Zhang, Yang Cao, Zefei Jiang
Translational Breast Cancer Research  
2020;
1:
7  
Review Article 
Tumor microenvironment and future targets of immunotherapy in breast cancer
Qi Wang, Qiang Liu
Translational Breast Cancer Research  
2020;
1:
6  
Guideline 
CSCO BC guideline: updates for HER2 positive breast cancer in 2020
Jianbin Li, Zefei Jiang
Translational Breast Cancer Research  
2020;
1:
4  
Guideline 
CSCO BC guideline: updates for hormone receptor-positive breast cancer in 2020
Fengrui Xu, Zefei Jiang
Translational Breast Cancer Research  
2020;
1:
3  
Editorial 
New therapeutic avenue of epigenetic modulations in cancer
Desi Pan, Xianping Lu
Translational Breast Cancer Research  
2020;
1:
2  
Foreword 
Welcome to Translational Breast Cancer Research
Zefei Jiang
Translational Breast Cancer Research  
2020;
1:
1